Compare CTNT & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTNT | CELZ |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 6.3M |
| IPO Year | 2023 | 2008 |
| Metric | CTNT | CELZ |
|---|---|---|
| Price | $1.38 | $1.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 41.8K | 16.5K |
| Earning Date | 03-20-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.74 | 32.08 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,288,536.00 | $6,000.00 |
| Revenue This Year | $235.67 | N/A |
| Revenue Next Year | $20.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 182.69 | N/A |
| 52 Week Low | $1.03 | $1.50 |
| 52 Week High | $2.12 | $6.25 |
| Indicator | CTNT | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 60.07 |
| Support Level | $1.36 | $1.72 |
| Resistance Level | $1.54 | $2.30 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 11.11 | 100.00 |
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: cargo storage, freight forwarding, U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.